Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Fractyl Health has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Fractyl Health's investors include General Catalyst, Bessemer Venture Partners, Catalio Capital Management, Taiwania Capital Management Corporation, True Ventures.
Fractyl Health is headquartered in Lexington, United States.
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Fractyl Health is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fractyl Health — Funding & Investors." VCBacked, September 26, 2025, https://www.vcbacked.co/company/fractyl-health. Accessed August 13, 2026.
VCBacked. (2025). Fractyl Health — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/fractyl-health
{{cite web |title=Fractyl Health — Funding & Investors |url=https://www.vcbacked.co/company/fractyl-health |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated